Filing Details
- Accession Number:
- 0001358403-18-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-11 16:02:01
- Reporting Period:
- 2018-01-09
- Accepted Time:
- 2018-01-11 16:02:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358403 | Bellicum Pharmaceuticals Inc | BLCM | Pharmaceutical Preparations (2834) | 201450200 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1705246 | K. Alan Smith | C/O Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030 | Evp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-01-09 | 487 | $9.40 | 2,087 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2017 by the Reporting Person.
Billionaire Hedge Funds
